InsiderClue
Insiders · Profile

MARAGANORE JOHN

Chief Executive Officer at ALNYLAM PHARMACEUTICALS · Director at AGIOS PHARMACEUTICALS. Filing since 28 Jun 2007. CIK 0001180432

ALNY ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer · 45 trades AGIO AGIOS PHARMACEUTICALS, INC. Director · 6 trades
Company
Date
Role
Action
Shares
Amount
Of holding
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Nov 2021
Chief Executive Officer
Sold, plan not stated
33,978
$5.83M
13.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Aug 2021
Chief Executive Officer
Sold, plan not stated
33,979
$6.79M
13.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 May 2021
Chief Executive Officer
Sold, plan not stated
33,979
$4.44M
13.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
25 Feb 2021
Chief Executive Officer
Sold, plan not stated
33,979
$5.01M
14.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 Nov 2020
Chief Executive Officer
Sold, plan not stated
34,765
$4.32M
15.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Aug 2020
Chief Executive Officer
Sold, plan not stated
34,765
$4.73M
15.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 May 2020
Chief Executive Officer
Sold, plan not stated
34,765
$4.98M
15.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Feb 2020
Chief Executive Officer
Sold, plan not stated
34,765
$4.58M
15.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 Oct 2019
Chief Executive Officer
Sold, plan not stated
49,456
$3.93M
20.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
15 May 2019
Chief Executive Officer
Sold, plan not stated
49,457
$3.46M
20.7%
AGIO AGIOS PHARMACEUTICALS, INC.
12 Sep 2018
Director
Sold, plan not stated
14,162
$1.02M
39.1%
AGIO AGIOS PHARMACEUTICALS, INC.
11 Sep 2018
Director
Sold, plan not stated
13,555
$986.13K
27.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
25 Jul 2018
Chief Executive Officer
Sold, plan not stated
50,000
$5.27M
24.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
22 Nov 2017
Chief Executive Officer
Sold, plan not stated
73,415
$9.61M
32.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
15 Nov 2017
Chief Executive Officer
Sold, plan not stated
74,000
$9.39M
33.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Jul 2016
CEO
Sold, plan not stated
15,075
$988.59K
10.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 Jul 2016
CEO
Sold, plan not stated
15,076
$962.00K
10.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Apr 2016
Chief Executive Officer
Sold, plan not stated
15,075
$1.02M
10.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 Apr 2016
Chief Executive Officer
Sold, plan not stated
15,076
$1.02M
10.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Jan 2016
Chief Executive Officer
Sold, plan not stated
15,076
$1.05M
10.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
19 Jan 2016
Chief Executive Officer
Sold, plan not stated
15,076
$1.12M
10.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
2 Dec 2015
Chief Executive Officer
Sold, plan not stated
58,689
$6.15M
30.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
20 Nov 2015
Chief Executive Officer
Sold, plan not stated
58,690
$6.04M
30.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
26 Jan 2015
Chief Executive Officer
Bought
10,000
$950.00K
8.9%
AGIO AGIOS PHARMACEUTICALS, INC.
16 Dec 2014
Director
Bought
1,806
$200.01K
3.7%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Sep 2014
Chief Executive Officer
Sold, plan not stated
56,834
$4.48M
35.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Sep 2014
Chief Executive Officer
Sold, plan not stated
56,834
$4.35M
35.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
26 Jun 2014
Chief Executive Officer
Sold, plan not stated
56,834
$3.68M
34.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
25 Jun 2014
Chief Executive Officer
Sold, plan not stated
56,834
$3.76M
34.8%
AGIO AGIOS PHARMACEUTICALS, INC.
23 Jun 2014
Director
Bought
2,300
$101.15K
4.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
15 May 2014
Chief Executive Officer
Sold, plan not stated
56,834
$3.19M
34.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 May 2014
Chief Executive Officer
Sold, plan not stated
56,834
$3.26M
34.8%
AGIO AGIOS PHARMACEUTICALS, INC.
29 Apr 2014
Director
Bought
2,250
$99.00K
5.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
11 Sep 2013
Chief Executive Officer
Sold, plan not stated
58,947
$3.27M
76.0%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 Aug 2013
Chief Executive Officer
Sold, plan not stated
60,000
$2.94M
76.3%
AGIO AGIOS PHARMACEUTICALS, INC.
24 Jul 2013
Director
Bought
8,333
$149.99K
23.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
10 Jul 2013
Chief Executive Officer
Sold, plan not stated
60,000
$2.23M
76.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
28 Feb 2013
Chief Executive Officer
Sold, plan not stated
28,503
$669.90K
60.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
27 Feb 2013
Chief Executive Officer
Sold, plan not stated
30,000
$704.02K
38.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
21 Feb 2012
CEO
Bought
5,581
$60.00K
10.5%
ALNY ALNYLAM PHARMACEUTICALS, INC.
9 Jan 2012
CEO
Bought
1,134
$9.99K
2.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Dec 2011
CEO
Bought
1,397
$10.00K
2.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 Nov 2011
CEO
Bought
1,411
$10.00K
2.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
11 Oct 2011
CEO
Bought
1,480
$9.99K
3.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Jun 2009
CEO
Sold, plan not stated
40,000
$854.65K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
17 Jun 2009
CEO
Sold, plan not stated
40,000
$855.84K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
16 Jun 2009
CEO
Sold, plan not stated
40,000
$857.59K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 Aug 2008
CEO
Sold, plan not stated
37,500
$1.28M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Aug 2008
CEO
Sold, plan not stated
37,500
$1.27M
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
29 Jun 2007
CEO
Sold, plan not stated
37,500
$584.27K
100%
ALNY ALNYLAM PHARMACEUTICALS, INC.
28 Jun 2007
CEO
Sold, plan not stated
37,500
$600.52K
100%
51 decisions on file.